Effect of Cheese on Cardiovascular Risk

NCT01739153 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2014-11-21

No results posted yet for this study

Summary

The main objective of the current study is to examine whether a high intake of regular-fat cheeses (Danbo and Cheddar) affect blood lipids differently than an isocaloric intake of either other fatty animal food products or of starchy carbohydrates. Furthermore, effects on fat digestibility, blood pressure, anthropometry, bile acid metabolism and insulin sensitivity is investigated.

To do this, a randomized crossover intervention study with 3x14 days full diet periods (cheese diet, meat diet or carb diet)will be conducted in 16 postmenopausal women. Between the diet periods there will be at least 14 days of wash-out where the subjects eat their habitual diets. Fasting blood samples will be drawn before and after the diet periods, and also a non-fasting blood sample will be drawn after the diet periods. Furthermore, total feces is collected the last 5 days of each diet period.

Conditions

Interventions

OTHER

Dietary intervention: CHEESE (High cheese intake)

OTHER

Dietary intervention: MEAT (High Meat intake)

OTHER

Dietary intervention: CARB (High Carbohydrate intake)

Sponsors & Collaborators

  • The Danish Dairy Research Foundation, Denmark

    collaborator OTHER
  • Dairy Research Institute

    collaborator OTHER
  • Dairy Farmers of Canada

    collaborator OTHER
  • Centre National Interprofessionel de l'Economie Laitière

    collaborator OTHER
  • Dairy Australia

    collaborator INDUSTRY
  • Nederlandse Zuivel Organisatie

    collaborator OTHER
  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Arne Astrup, Prof, MD · Head of Department of Nutrition, Exercise and Sports

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
68 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-08-31
Completion
2014-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739153 on ClinicalTrials.gov